Bioanalytical Technologies' mission is to support the IBRI's research areas by helping to innovate the next generation of bioanalytical systems and methods. These efforts support and help enable the IBRI's development of new standards of patient care and therapeutics.

Dr. Michael Pugia is leading the development of state-of-the art technology platforms and methods for bioanalytical applications in life sciences. These tools make it possible to measure the most basic elements of cell biology and solve today’s problems in biomolecular analysis with detection limits far lower than current methods. This enables far greater clarity for studying the complexity of biological systems.

Lab Team

Highlights and Publications

  • Pugia, Michael & J Newman, David & A Lott, John & D'Mello, Lucia & Clark, Larry & A Profitt, James & Cast, Todd. (2003). Detection of low-molecular-weight proteins in urine by dipsticks. Clinica chimica acta; international journal of clinical chemistry. 326. 177-83. 10.1016/S0009-8981(02)00304-2. 
  • Pugia, Michael & Takemura, Toskihiho & Kuwajima, Shiro & Suzuki, Motoyohisa & K Cast, Todd & A Profit, James & S Schulman, Lloyd & Ohta, Yoshihide & A Lott, John. (2002). Clinical utility of a rapid test for uristatin. Clinical biochemistry. 35. 105-10. 10.1016/S0009-9120(02)00288-6.
  • A. Bartsch, Richard & L. Cowey, Charles & Elshani, Sadik & Goo, Mi-Ja & Huber, Vincent & N. Ivy, Sheryl & J. Johnson, Russell & Seung Kim, Jong & Luboch, Elzbieta & A. Mcdonough, Joseph & Pugia, Michael & Son, Byungki. (2001). Synthesis of lariat ether carboxylic acids based on dibenzo-16-crown-5. Journal of Heterocyclic Chemistry - J HETEROCYCL CHEM. 38. 311-331. 10.1002/jhet.5570380201.
  • Shihabi, Zak & P Schwartz, R & Pugia, Michael. (2001). Decreasing the variability observed in urine analysis. Annals of clinical and laboratory science. 31. 99-102. 

View All of Mike Pugia's Publications